Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Cannabis Science Inc    

 SummaryNewsCompany 
Company
Cannabis Science, Inc. develops cannabis pharmaceutical products.The company works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.Cannabis Science was founded by... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on CANNABIS SCIENCE INC
07/17 CANNABIS SCIENCE, INC. : Finds Large-Scale Manufacturing and Product Distributio..
07/07 CANNABIS SCIENCE : Steps Up the Fight Against Opioid Drug Addictions with its In..
07/05 CANNABIS SCIENCE : Releases its 2017 Guidance Report for 2nd Quarter 2017, and O..
06/28 CANNABIS SCIENCE : Calls on All MMJ Companies to Recognize and Join the Fight Ag..
06/23 CANNABIS SCIENCE : Invests in the Research and Development of Cannabinoid-based ..
06/22 CANNABIS SCIENCE : UPDATE - Cannabis Science Releases the Chronic Pain CBIS Tran..
06/22 CANNABIS SCIENCE : Releases the Chronic Pain CBIS Transdermal Patches to Meet th..
05/26 CANNABIS SCIENCE, INC. : Receives U.S. Federal Government Clearance to Receive U..
05/17 CANNABIS SCIENCE, INC. (OTCMKTS : CBIS) Files An 8-K Entry into a Material Defin..
05/17 CANNABIS SCIENCE, INC. : Entry into a Material Definitive Agreement (form 8-K)
More news
Sector news : Bio Therapeutic Drugs
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/12 FDA panel backs Novartis' pioneering new cancer gene therapy
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
More sector news : Bio Therapeutic Drugs
Managers
NameTitle
Raymond C. Dabney President, Chief Executive Officer & Director
Robert Kane Chief Operating Officer & Director
Benjamin C. K. Tam Chief Financial Officer, Secretary & Director
Richard Ogden Chief Scientific Officer
Allen A. Herman Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
CANNABIS SCIENCE INC0
AMGEN23.25%132 526
CELGENE CORPORATION19.00%107 551
GILEAD SCIENCES3.00%96 384
REGENERON PHARMACEUTICALS40.54%54 837
VERTEX PHARMACEUTICALS121.49%40 641